DiscoverLung Cancer VoicesEp 105. The Role of Pharma on the Path to New Medicines: A Conversation With IMC
Ep 105. The Role of Pharma on the Path to New Medicines:  A Conversation With IMC

Ep 105. The Role of Pharma on the Path to New Medicines: A Conversation With IMC

Update: 2025-11-07
Share

Description

In this episode, Dr. Paul Wheatley-Price chats with Dr. Bettina Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada.

Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/
Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep 105. The Role of Pharma on the Path to New Medicines:  A Conversation With IMC

Ep 105. The Role of Pharma on the Path to New Medicines: A Conversation With IMC

Lung Cancer Canada